Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014;54(1):17-22.
doi: 10.2176/nmc.oa2013-0196. Epub 2013 Nov 20.

Detailed analysis of puncture site vascular complications in Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2

Masayuki Sato  1 , Yuji Matsumaru, Nobuyuki Sakai, Shinichi Yoshimura; JR-NET Study Group Affiliations
Collaborators, Affiliations
Multicenter Study

Detailed analysis of puncture site vascular complications in Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2

Masayuki Sato et al. Neurol Med Chir (Tokyo). 2014.

Abstract

A subgroup analysis of access site complications in the Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2, which were retrospective registry studies, was performed. Puncture site vascular complications occurred in 195 (0.63%, mean age: 69.2) of all 31,836 patients. Most of these complications resulted from surgery in main hospitals (186 patients, 0.67%, P < 0.001) and scheduled surgery (167 patients, 0.73%, P < 0.001). Carotid artery stenting (81 patients, 1.04%, p < 0.001), extracranial percutaneous transluminal angioplasty (PTA) (15 patients, 1.02%, p < 0.001), and intracranial PTA (10 patients, 0.81%, p < 0.05) were associated with significantly higher incidence of complications. The incidence of puncture site vascular complications was correlated with the number of antiplatelet drugs (p < 0.001) and intraoperative heparinization (p < 0.05).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest Disclosure

The authors declare no conflicts of interest. All authors who are members of The Japan Neurosurgical Society (JNS) have registered online Self-reported COI Disclosure Statement Forms through the website for JNS members.

Figures

Fig. 1
Fig. 1
Use of antiplatelet drugs by treatment. PTA: percutaneous transluminal angioplasty.
Fig. 2
Fig. 2
Univariate analysis of status of antiplatelet agents. The incidence of access site complications was significantly different between patients receiving 3 antiplatelet drugs and those receiving 1 or 2 drugs, between those receiving 1 or 2 drugs and those receiving none, and between those receiving 3 drugs and those receiving none. PTA: percutaneous transluminal angioplasty.
Fig. 3
Fig. 3
Univariate analysis of effect of using heparin in each treatment. The incidence of access site complications was significantly different between heparinized patients and non-heparinized patients, between heparinized patients who underwent aneurysm embolization and heparinized patients who underwent carotid artery stenting, and between heparinized patients who underwent aneurysm embolization and heparinized patients who underwent extracranial PTA. PTA: percutaneous transluminal angioplasty
See this image and copyright information in PMC

Republished in

References

    1. Das R, Ahmed K, Athanasiou T, Morgan RA, Belli AM: Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 34: 723– 738, 2011. - PubMed
    1. Upponi SS, Ganeshan AG, Warakaulle DR, Phillips-Hughes J, Boardman P, Uberoi R: Angioseal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures—a randomized controlled trial. Eur J Radiol 61: 332– 334, 2007. - PubMed
    1. Vaitkus PT: A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol 16: 243– 246, 2004. - PubMed
    1. Veasey RA, Large JK, Silberbauer J, Paul G, Taggu W, Ellery S, Rathore VS, Lloyd GW, Patel NR, Sulke AN: A randomised controlled trial comparing Star-Close and AngioSeal vascular closure devices in a district general hospital—the SCOAST study. Int J Clin Pract 62: 912– 918, 2008. - PubMed
    1. Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M: Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 291: 350– 357, 2004. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources